Adipokines as therapeutic targets in breast cancer treatment

Yoon Jin Cha, Ja Seung Koo

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Introduction: Adipocytes, which represent a substantial part of the tumor microenvironment in breast cancer, secrete several adipokines that affect tumorigenesis, cancer progression, metastasis, and treatment resistance via multiple signaling pathways. Areas covered: In this review, we focus on the role of leptin, adiponectin, autotaxin, and interleukin-6 in breast cancer initiation, progression, metastasis, and drug response. Furthermore, we investigated adipokines as potential targets of breast cancer-specific drugs. Expert opinion: Adipokines and adipokine receptors are deregulated in breast cancer. Adipokines play various roles in breast cancer initiation, progression, metastasis, and drug response, hence, adipokine signaling could be an effective drug target. Several clinical trials are in progress to test the efficacy of adipokine targeting agents. However, adipokines also affect metabolic homeostasis; hence, the adverse effects of the targeted drug should be investigated and addressed.

Original languageEnglish
Pages (from-to)941-953
Number of pages13
JournalExpert Opinion on Therapeutic Targets
Volume22
Issue number11
DOIs
Publication statusPublished - 2018 Nov 2

Fingerprint

Adipokines
Oncology
Breast Neoplasms
Pharmaceutical Preparations
Adipokine Receptors
Neoplasm Metastasis
Therapeutics
Tumor Microenvironment
Adiponectin
Expert Testimony
Leptin
Adipocytes
Tumors
Interleukin-6
Carcinogenesis
Homeostasis
Clinical Trials

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

@article{ea254a7a81b4409d93ba9034d8afe66a,
title = "Adipokines as therapeutic targets in breast cancer treatment",
abstract = "Introduction: Adipocytes, which represent a substantial part of the tumor microenvironment in breast cancer, secrete several adipokines that affect tumorigenesis, cancer progression, metastasis, and treatment resistance via multiple signaling pathways. Areas covered: In this review, we focus on the role of leptin, adiponectin, autotaxin, and interleukin-6 in breast cancer initiation, progression, metastasis, and drug response. Furthermore, we investigated adipokines as potential targets of breast cancer-specific drugs. Expert opinion: Adipokines and adipokine receptors are deregulated in breast cancer. Adipokines play various roles in breast cancer initiation, progression, metastasis, and drug response, hence, adipokine signaling could be an effective drug target. Several clinical trials are in progress to test the efficacy of adipokine targeting agents. However, adipokines also affect metabolic homeostasis; hence, the adverse effects of the targeted drug should be investigated and addressed.",
author = "Cha, {Yoon Jin} and Koo, {Ja Seung}",
year = "2018",
month = "11",
day = "2",
doi = "10.1080/14728222.2018.1538356",
language = "English",
volume = "22",
pages = "941--953",
journal = "Expert Opinion on Therapeutic Targets",
issn = "1472-8222",
publisher = "Informa Healthcare",
number = "11",

}

Adipokines as therapeutic targets in breast cancer treatment. / Cha, Yoon Jin; Koo, Ja Seung.

In: Expert Opinion on Therapeutic Targets, Vol. 22, No. 11, 02.11.2018, p. 941-953.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Adipokines as therapeutic targets in breast cancer treatment

AU - Cha, Yoon Jin

AU - Koo, Ja Seung

PY - 2018/11/2

Y1 - 2018/11/2

N2 - Introduction: Adipocytes, which represent a substantial part of the tumor microenvironment in breast cancer, secrete several adipokines that affect tumorigenesis, cancer progression, metastasis, and treatment resistance via multiple signaling pathways. Areas covered: In this review, we focus on the role of leptin, adiponectin, autotaxin, and interleukin-6 in breast cancer initiation, progression, metastasis, and drug response. Furthermore, we investigated adipokines as potential targets of breast cancer-specific drugs. Expert opinion: Adipokines and adipokine receptors are deregulated in breast cancer. Adipokines play various roles in breast cancer initiation, progression, metastasis, and drug response, hence, adipokine signaling could be an effective drug target. Several clinical trials are in progress to test the efficacy of adipokine targeting agents. However, adipokines also affect metabolic homeostasis; hence, the adverse effects of the targeted drug should be investigated and addressed.

AB - Introduction: Adipocytes, which represent a substantial part of the tumor microenvironment in breast cancer, secrete several adipokines that affect tumorigenesis, cancer progression, metastasis, and treatment resistance via multiple signaling pathways. Areas covered: In this review, we focus on the role of leptin, adiponectin, autotaxin, and interleukin-6 in breast cancer initiation, progression, metastasis, and drug response. Furthermore, we investigated adipokines as potential targets of breast cancer-specific drugs. Expert opinion: Adipokines and adipokine receptors are deregulated in breast cancer. Adipokines play various roles in breast cancer initiation, progression, metastasis, and drug response, hence, adipokine signaling could be an effective drug target. Several clinical trials are in progress to test the efficacy of adipokine targeting agents. However, adipokines also affect metabolic homeostasis; hence, the adverse effects of the targeted drug should be investigated and addressed.

UR - http://www.scopus.com/inward/record.url?scp=85056086635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056086635&partnerID=8YFLogxK

U2 - 10.1080/14728222.2018.1538356

DO - 10.1080/14728222.2018.1538356

M3 - Review article

C2 - 30332900

AN - SCOPUS:85056086635

VL - 22

SP - 941

EP - 953

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

SN - 1472-8222

IS - 11

ER -